The outcome of oxygen therapy on desaturated patient with moderate to severe symptoms in Kogabwilhan II Indrapura Field Hospital

Hafizh Rizky Prasetya; Erwin Astha Triyono; Paulus Budiono Notopuro; Leny Kartina

doi:10.15562/ism.v14i2.1580

The outcome of oxygen therapy on desaturated patient with moderate to severe symptoms in Kogabwilhan II Indrapura Field Hospital

Hafizh Rizky Prasetya ,

Erwin Astha Triyono ,

Paulus Budiono Notopuro ,

Leny Kartina ,

pdf |
DOI: https://doi.org/10.15562/ism.v14i2.1580 |
Published: 2023-08-30

Abstract

Background: Since the first outbreak of Coronavirus Disease 2019 (COVID-19) in late 2019 in Wuhan, the SARS-CoV virus has grown rapidly and spread around the globe. The virus invades respiratory epithelium, causing inflammation and damage to lung cells, which causes impaired gas exchange and leads to a desaturated state. Kogabwilhan II Indrapura Field Hospital in Surabaya was an initial emergency hospital for asymptomatic and mild-symptomatic COVID-19 patients. Due to the massive surge of COVID-19 cases in East Java, it had to treat moderate and severe symptomatic patients.

Aim: The study aims to report clinical prognosis post-COVID-19 infection.

Method: This is a retrospective descriptive study in Kogabwilhan II Indrapura Field Hospital with desaturated COVID-19 patients from March 2020 to October 2021 as samples.

Results: Of 471 admitted COVID-19 patients with desaturation, 36.9% were moderate-symptomatic, and 63.9% had severe ones. All patients received oxygen therapy and multivitamins. Then, 29.7% of patients were cured, while 70.3% were referred. 48.4% of referred patients were bonam, 10.2% were pronounced deceased, and 11.7% were unknown.

Conclusion: Most patients declared cured after being referred to another center.

References

Cao Y, Hiyoshi A, Montgomery S. COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data. BMJ open. 2020 Nov 1;10(11):e043560.
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama. 2020 May 12;323(18):1775-6.
Panicacci S, Giuffrida G, Donati M, Lubrano A, Ruiu A, Fanucci L. Empowering home health monitoring of COVID-19 patients with smartwatch position and fitness tracking. In2021 IEEE 34th International Symposium on Computer-Based Medical Systems (CBMS) 2021 Jun 7 (pp. 348-353).
Ji YL, Yang WU, Zhen QI, Hao MI, Zhang Y, Zhang AN, Yan LE, Xia ZY. The pathogenesis and treatment of COVID-19: A system review. Biomedical and Environmental Sciences. 2021 Jan 1;34(1):50-60.
Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future microbiology. 2020 Sep;15(13):1287-305.
Parasher A. COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgraduate medical journal. 2021 May 1;97(1147):312-20.
Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, Xiao W, Yao S, Mei W, Chen X, Luo A. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. British journal of anaesthesia. 2020 Jul 1;125(1):e28-37.
Sorbello M, El‐Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, Merli G, Cortese G, Corso RM, Bressan F, Pintaudi S. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020 Jun;75(6):724-32.
Zareifopoulos N, Lagadinou M, Karela A, Karantzogiannis G, Velissaris D. Intubation and mechanical ventilation of patients with COVID-19: what should we tell them? Monaldi Archives for Chest Disease. 2020 Apr 8;90(1).
Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney international. 2020 Jul 1;98(1):219-27.
Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 2020 Jun;18(6):1421-4.
Lee, K.Y. Pneumonia, acute respiratory distress syndrome, and early immune-modulator therapy. International Journal of Molecular Sciences, 2017; 18(2), p.388.
Ketenci S, Aynacıoğlu AŞ. The growth factor/cytokine midkine may participate in cytokine storm and contribute to the pathogenesis of severe acute respiratory syndrome coronavirus 2-infected patients. The Egyptian Journal of Bronchology. 2021 Dec;15(1):1-6.
Kesehatan K. Pedoman Pencegahan dan Pengendalian Corona Virus deases (Covid-19). Kementrian Kesehat [Internet]. 2020; 5:178. Accessed: January 2020. Available from: https://covid19.go.id/storage/app/media/Protokol/REV-05_Pedoman_P2_COVID-19_13_Juli_2020.pdf
Wahyuhadi J, Triyono EA, Waloejo CS, Harianto A, Jaya HP, Aulia FA, Iswara ND, Harianto MA, Murti K, Sriyono S, Kiranasari NH. Therapy for patients with asymptomatic and mild cases of COVID-19 in Indonesia. F1000Research. 2021 Sep 7;10(898):898.
Jiang B, Wei H. Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients. Eur Rev Med Pharmacol Sci. 2020 Oct 1;24(19):10239-46.
Yousefifard, M., Zali, A., Ali, K.M., Neishaboori, A.M., Zarghi, A., Hosseini, M. and Safari, S. Antiviral therapy in management of COVID-19: a systematic review on current evidence. Archives of academic emergency medicine, 2020; 8(1).
Hadiyanto, M.L. Gambaran hingga tatalaksana COVID-19 pada anak. Intisari Sains Medis 2021;12(1): 250-255. DOI: 10.15562/ism.v12i1.947
Donina ZA. Causes of Hypoxemia in COVID-19. Journal of Evolutionary Biochemistry and Physiology. 2022 Jan;58(1):73-80.

[1] Cao Y, Hiyoshi A, Montgomery S. COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data. BMJ open. 2020 Nov 1;10(11):e043560.

[2] Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama. 2020 May 12;323(18):1775-6.

[3] Panicacci S, Giuffrida G, Donati M, Lubrano A, Ruiu A, Fanucci L. Empowering home health monitoring of COVID-19 patients with smartwatch position and fitness tracking. In2021 IEEE 34th International Symposium on Computer-Based Medical Systems (CBMS) 2021 Jun 7 (pp. 348-353).

[4] Ji YL, Yang WU, Zhen QI, Hao MI, Zhang Y, Zhang AN, Yan LE, Xia ZY. The pathogenesis and treatment of COVID-19: A system review. Biomedical and Environmental Sciences. 2021 Jan 1;34(1):50-60.

[5] Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future microbiology. 2020 Sep;15(13):1287-305.

[6] Parasher A. COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgraduate medical journal. 2021 May 1;97(1147):312-20.

[7] Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, Xiao W, Yao S, Mei W, Chen X, Luo A. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. British journal of anaesthesia. 2020 Jul 1;125(1):e28-37.

[8] Sorbello M, El‐Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, Merli G, Cortese G, Corso RM, Bressan F, Pintaudi S. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020 Jun;75(6):724-32.

[9] Zareifopoulos N, Lagadinou M, Karela A, Karantzogiannis G, Velissaris D. Intubation and mechanical ventilation of patients with COVID-19: what should we tell them? Monaldi Archives for Chest Disease. 2020 Apr 8;90(1).

[10] Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney international. 2020 Jul 1;98(1):219-27.

[11] Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 2020 Jun;18(6):1421-4.

[12] Lee, K.Y. Pneumonia, acute respiratory distress syndrome, and early immune-modulator therapy. International Journal of Molecular Sciences, 2017; 18(2), p.388.

[13] Ketenci S, Aynacıoğlu AŞ. The growth factor/cytokine midkine may participate in cytokine storm and contribute to the pathogenesis of severe acute respiratory syndrome coronavirus 2-infected patients. The Egyptian Journal of Bronchology. 2021 Dec;15(1):1-6.

[14] Kesehatan K. Pedoman Pencegahan dan Pengendalian Corona Virus deases (Covid-19). Kementrian Kesehat [Internet]. 2020; 5:178. Accessed: January 2020. Available from: https://covid19.go.id/storage/app/media/Protokol/REV-05_Pedoman_P2_COVID-19_13_Juli_2020.pdf

[15] Wahyuhadi J, Triyono EA, Waloejo CS, Harianto A, Jaya HP, Aulia FA, Iswara ND, Harianto MA, Murti K, Sriyono S, Kiranasari NH. Therapy for patients with asymptomatic and mild cases of COVID-19 in Indonesia. F1000Research. 2021 Sep 7;10(898):898.

[16] Jiang B, Wei H. Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients. Eur Rev Med Pharmacol Sci. 2020 Oct 1;24(19):10239-46.

[17] Yousefifard, M., Zali, A., Ali, K.M., Neishaboori, A.M., Zarghi, A., Hosseini, M. and Safari, S. Antiviral therapy in management of COVID-19: a systematic review on current evidence. Archives of academic emergency medicine, 2020; 8(1).

[18] Hadiyanto, M.L. Gambaran hingga tatalaksana COVID-19 pada anak. Intisari Sains Medis 2021;12(1): 250-255. DOI: 10.15562/ism.v12i1.947

[19] Donina ZA. Causes of Hypoxemia in COVID-19. Journal of Evolutionary Biochemistry and Physiology. 2022 Jan;58(1):73-80.

The outcome of oxygen therapy on desaturated patient with moderate to severe symptoms in Kogabwilhan II Indrapura Field Hospital

Abstract

References

How to Cite

Search Panel